Table 2.

Proportional decrease in recurrences and mortality with adjuvant tamoxifen in patients with ER-positive (ER+) and ER-negative (ER−) tumors.

Tamoxifen treatmentRecurrence, %Mortality, %
ER+ER−ER+ER−
1 year216146
2 years2813187
5 years50628−3